U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 114

1.
E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer
Shirley Jusino, Yainyrette Rivera-Rivera, Camille Chardón-Colón, Armando J Ruiz-Justiz, Jaleisha Vélez-Velázquez, Angel Isidro, Melanie E Cruz-Robles, Margarita Bonilla-Claudio, Guillermo N Armaiz-Pena, Harold I Saavedra
Exp Biol Med (Maywood) 2021 Oct; 246(19): 2057–2071. Published online 2021 Aug 9. doi: 10.1177/15353702211035693
PMCID:
PMC8524769
AbstractArticlePDF–2.5M
2.
Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype
Tong Xu, Hong-Tao Li, Jenny Wei, Meng Li, Tien-Chan Hsieh, Yi-Tsung Lu, Ranjani Lakshminarasimhan, Rong Xu, Emmanuelle Hodara, Gareth Morrison, Hemant Gujar, Suhn Kyong Rhie, Kimberly Siegmund, Gangning Liang, Amir Goldkorn
Int J Cancer. Author manuscript; available in PMC 2021 Jun 1.
Published in final edited form as: Int J Cancer. 2020 Jun 1; 146(11): 3065–3076. Published online 2020 Feb 22. doi: 10.1002/ijc.32904
PMCID:
PMC7448727
AbstractArticlePDF–963K
3.
Mitochondrial protein E2F3d, a distinctive E2F3 product, mediates hypoxia-induced mitophagy in cancer cells
Keigo Araki, Keiko Kawauchi, Wataru Sugimoto, Daisuke Tsuda, Hiroya Oda, Ryosuke Yoshida, Kiyoshi Ohtani
Commun Biol. 2019; 2: 3. Published online 2019 Jan 3. doi: 10.1038/s42003-018-0246-9
PMCID:
PMC6318215
AbstractArticlePDF–4.9M
4.
E2F Inhibition Synergizes with Paclitaxel in Lung Cancer Cell Lines
Courtney A. Kurtyka, Lu Chen, W. Douglas Cress
PLoS One. 2014; 9(5): e96357. Published online 2014 May 15. doi: 10.1371/journal.pone.0096357
PMCID:
PMC4022639
AbstractArticlePDF–954K
5.
Overexpression of E2F3 promotes proliferation of functional human β cells without induction of apoptosis
Brian Rady, Yanmei Chen, Pilar Vaca, Qian Wang, Yong Wang, Patrick Salmon, José Oberholzer
Cell Cycle. 2013 Aug 15; 12(16): 2691–2702. Published online 2013 Jul 29. doi: 10.4161/cc.25834
Correction in:
Cell Cycle. 2016; 15(17): 2376.
PMCID:
PMC3865059
AbstractArticlePDF–2.6M
6.
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Hui-Zi Chen, Shih-Yin Tsai, Gustavo Leone
Nat Rev Cancer. Author manuscript; available in PMC 2013 Apr 4.
Published in final edited form as: Nat Rev Cancer. 2009 Nov; 9(11): 785–797. doi: 10.1038/nrc2696
PMCID:
PMC3616489
AbstractArticlePDF–953K
7.
The E2F3—Oncomir 1 axis is activated in Wilms Tumor
Eric J. Kort, Leslie Farber, Maria Tretiakova, David Petillo, Kyle A. Furge, Ximing J. Yang, Albert Cornelius, Bin T. Teh
Cancer Res. Author manuscript; available in PMC 2009 Jun 1.
Published in final edited form as: Cancer Res. 2008 Jun 1; 68(11): 4034–4038. doi: 10.1158/0008-5472.CAN-08-0592
PMCID:
PMC2442735
AbstractArticlePDF–1.0M
8.
Evaluation of biological pathways involved in chemotherapy response in breast cancer
Attila Tordai, Jing Wang, Fabrice Andre, Cornelia Liedtke, Kai Yan, Christos Sotiriou, Gabriel N Hortobagyi, W Fraser Symmans, Lajos Pusztai
Breast Cancer Res. 2008; 10(2): R37. Published online 2008 Apr 29. doi: 10.1186/bcr2088
PMCID:
PMC2397539
AbstractArticlePDF–709K
9.
Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification
Carolyn D. Hurst, Darren C. Tomlinson, Sarah V. Williams, Fiona M. Platt, Margaret A. Knowles
Oncogene. Author manuscript; available in PMC 2008 Oct 24.
Published in final edited form as: Oncogene. 2008 Apr 24; 27(19): 2716–2727. Published online 2007 Nov 26. doi: 10.1038/sj.onc.1210934
PMCID:
PMC2387074
AbstractArticlePDF–4.6M
10.
E2F3 activity is regulated during the cell cycle and is required for the induction of S phase
Gustavo Leone, James DeGregori, Zhen Yan, Laszlo Jakoi, Seiichi Ishida, R. Sanders Williams, Joseph R. Nevins
Genes Dev. 1998 Jul 15; 12(14): 2120–2130. doi: 10.1101/gad.12.14.2120
PMCID:
PMC317011
AbstractArticlePDF–971K
11.
Complex Transcriptional Regulatory Mechanisms Control Expression of the E2F3 Locus
Monique R. Adams, Rosalie Sears, Faison Nuckolls, Gustavo Leone, Joseph R. Nevins
Mol Cell Biol. 2000 May; 20(10): 3633–3639. doi: 10.1128/mcb.20.10.3633-3639.2000
PMCID:
PMC85656
AbstractArticlePDF–385K
12.
Interaction of E2F3a and CASP8AP2 Regulates Histone Expression and Chemosensitivity of Leukemic Cells
Fen-fen Jin, Chan-juan Wang, Lei Cui, Fei-fei Liu, Kai-ling Wang, Wei-jing Li, Zhi-gang Li
J Pediatr Hematol Oncol. 2023 Apr; 45(3): e339–e344. Published online 2022 Sep 22. doi: 10.1097/MPH.0000000000002558
PMCID:
PMC10030168
AbstractArticlePDF–473K
13.
Hsa_hsa_circ_0081069 promotes the progression of colorectal cancer through sponging miR‐665 and regulating E2F3 expression
Jingjing Xie, Dan Jin, Jinyin Xu, Fei Yang, Jianying Jin
J Clin Lab Anal. 2022 Nov; 36(11): e24710. Published online 2022 Sep 30. doi: 10.1002/jcla.24710
PMCID:
PMC9701882
AbstractArticlePDF–12M
14.
Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts
Haiwei Wang, Xinrui Wang, Liangpu Xu, Ji Zhang
BMC Pediatr. 2022; 22: 376. Published online 2022 Jun 29. doi: 10.1186/s12887-022-03424-w
PMCID:
PMC9241263
AbstractArticlePDF–9.4M
15.
CircularRNA_0119872 regulates the microRNA-582-3p/E2F transcription factor 3 pathway to promote the progression of malignant melanoma
Jinlong Qu, Chunying Yuan, Qi Jia, Mengwei Sun, Min Jiang, Fuguang Zuo
Clinics (Sao Paulo) 2021; 76: e3036. Published online 2021 Sep 28. doi: 10.6061/clinics/2021/e3036
PMCID:
PMC8478137
AbstractArticlePDF–1.3M
16.
MicroRNA-152 Suppresses Human Osteosarcoma Cell Proliferation and Invasion by Targeting E2F Transcription Factor 3
Chao Ma, Jinfeng Han, Dong Dong, Nanya Wang
Oncol Res. 2018; 26(5): 765–773. Published online 2018 Jun 11. doi: 10.3727/096504017X15021536183535
PMCID:
PMC7844728
AbstractArticlePDF–6.3M
17.
Knockdown of E2F3 Inhibits Proliferation, Migration, and Invasion and Increases Apoptosis in Glioma Cells
Zhi-Gang Shen, Xiao-Zhou Liu, Chang-Xiu Chen, Jing-Min Lu
Oncol Res. 2017; 25(9): 1555–1566. Published online 2017 Nov 2. doi: 10.3727/096504017X14897158009178
PMCID:
PMC7841128
AbstractArticlePDF–10M
18.
Loss of lncRNA MIAT ameliorates proliferation and fibrosis of diabetic nephropathy through reducing E2F3 expression
Ting‐Ting Ji, Ying‐Hui Qi, Xiao‐Ying Li, Bo Tang, Ya‐Kun Wang, Peng‐Xi Zheng, Weiliang Li, Xiaolei Qu, Linhong Feng, Shou‐Jun Bai
J Cell Mol Med. 2020 Nov; 24(22): 13314–13323. Published online 2020 Oct 3. doi: 10.1111/jcmm.15949
PMCID:
PMC7701586
AbstractArticlePDF–1.2M
19.
Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells
Chao Gao, Shu-Guang Liu, Wen-Ting Lu, Zhi-Xia Yue, Xiao-Xi Zhao, Tian-Yu Xing, Zhen-Ping Chen, Hu-Yong Zheng, Zhi-Gang Li
Mol Med Rep. 2020 Oct; 22(4): 2905–2915. Published online 2020 Jul 17. doi: 10.3892/mmr.2020.11347
PMCID:
PMC7453649
AbstractArticlePDF–1.0M
20.
MicroRNA-145-5p inhibits osteosarcoma cell proliferation by targeting E2F transcription factor 3
Hao Li, Runsang Pan, Qiaoying Lu, Chong Ren, Junkang Sun, Huaping Wu, Jing Wen, Houping Chen
Int J Mol Med. 2020 May; 45(5): 1317–1326. Published online 2020 Feb 17. doi: 10.3892/ijmm.2020.4504
PMCID:
PMC7138290
AbstractArticlePDF–1.7M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center